Filed: 11/14/2023ACC: 0001012975-23-000461
📋 What this filing means
ARCH VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $153.96M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$153.96M
Total AUM (reported)
62.95M
Total Shares
Allocation by class
COM$153.96M100.0%
Portfolio Concentration
Top 3$129.08M83.8%
4–10$24.88M16.2%
Top 3 weight
83.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 62.95M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
62.95M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings7
Rows:
EQRX, INC.
SOLEShares36.34M
TypeSH
Market value$80.66M
52.39%
Sole
0.00
Shared
0.00
None
36.34M
VERVE THERAPEUTICS, INC.
SOLEShares2.01M
TypeSH
Market value$26.64M
17.30%
Sole
0.00
Shared
0.00
None
2.01M
ERASCA, INC.
SOLEShares11.06M
TypeSH
Market value$21.78M
14.15%
Sole
0.00
Shared
0.00
None
11.06M
DENALI THERAPEUTICS, INC.
SOLEShares693.75K
TypeSH
Market value$14.31M
9.30%
Sole
0.00
Shared
0.00
None
693.75K
GOSSAMER BIO, INC.
SOLEShares8.06M
TypeSH
Market value$6.71M
4.36%
Sole
0.00
Shared
0.00
None
8.06M
UNITY BIOTECHNOLOGY, INC.
SOLEShares1M
TypeSH
Market value$2.41M
1.57%
Sole
0.00
Shared
0.00
None
1M
SINGULAR GENOMICS SYSTEMS, INC.
SOLEShares3.80M
TypeSH
Market value$1.45M
0.94%
Sole
0.00
Shared
0.00
None
3.80M
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
EQRX, INC.SOLE | COM | 36.34M | SH | $80.66M 52.39% | 0.00 | 0.00 | 36.34M |
VERVE THERAPEUTICS, INC.SOLE | COM | 2.01M | SH | $26.64M 17.30% | 0.00 | 0.00 | 2.01M |
ERASCA, INC.SOLE | COM | 11.06M | SH | $21.78M 14.15% | 0.00 | 0.00 | 11.06M |
DENALI THERAPEUTICS, INC.SOLE | COM | 693.75K | SH | $14.31M 9.30% | 0.00 | 0.00 | 693.75K |
GOSSAMER BIO, INC.SOLE | COM | 8.06M | SH | $6.71M 4.36% | 0.00 | 0.00 | 8.06M |
UNITY BIOTECHNOLOGY, INC.SOLE | COM | 1M | SH | $2.41M 1.57% | 0.00 | 0.00 | 1M |
SINGULAR GENOMICS SYSTEMS, INC.SOLE | COM | 3.80M | SH | $1.45M 0.94% | 0.00 | 0.00 | 3.80M |